RESÚMENES ENERO 2007

.

Basic Neuroscience & Pharmacology

(Haga un click en la información del journal para acceder al resúmen)

 

The Genetics of Gambling and Behavioral Addictions

Daniela S.S. Lobo, and James L. Kennedy

CNS Spectr. 2006;11(12)931-939

TEXTO GRATUITO

 

Role of atypical opiates in OCD. Experimental approach through the study of 5-HT2A/C receptor-mediated behavior

Original Investigation

Role of atypical opiates in OCD. Experimental approach through the study of 5-HT2A/C receptor-mediated behavior

M. Olga Rojas-Corrales, Juan Gibert-Rahola and Juan A. Mico

Psychopharmacology. Volume 190, Number 2 / February, 2007: 221-231

 

Frontal anatomy and reaction time in Autism

Nicole Schmitz, Eileen Daly and Declan Murphy

Neuroscience Letters. Volume 412, Issue 1, 22 January 2007, Pages 12-17

 

Mitochondrial Dysfunction as the Molecular Basis of Bipolar Disorder: Therapeutic Implications

Kato, Tadafumi

CNS Drugs. 21(1):1-11, 2007

How and Why Genetic Linkage Has Not Solved the Problem of Psychosis: Review and Hypothesis

Timothy J. Crow

Am J Psychiatry 164:13-21, January 2007

Competition for neuronal resources: how hallucinations make themselves heard

DANIELA HUBL, THOMAS KOENIG, WERNER K. STRIK, LESTER MELIE GARCIA, THOMAS DIERKS

The British Journal of Psychiatry (2007) 190: 57-62

Changes in regional cerebral blood flow during acute electroconvulsive therapy in patients with depression. Positron emission tomographic study

HARUMASA TAKANO, NOBUTAKA MOTOHASHI, TAKESHI UEMA, KENICHI OGAWA, TAKASHI OHNISHI, MASAMI NISHIKAWA, HARUO KASHIMA, HIROSHI MATSUDA

The British Journal of Psychiatry (2007) 190: 63-68

Allopregnanolone reduces immobility in the forced swimming test and increases the firing rate of lateral septal neurons through actions on the GABAA receptor in the rat

Juan Francisco Rodrìguez-Landa

Journal of Psychopharmacology, Vol. 21, No. 1, 76-84 (2007)

Kynurenine pathway in major depression: Evidence of impaired neuroprotection

Aye-Mu Myint, Yong Ku Kim, Robert Verkerk, Simon Scharpé, Harry Steinbusch and Brian Leonard

Journal of Affective Disorders. Volume 98, Issues 1-2, February 2007, Pages 143-151

 

A systematic review comparing the functional neuroanatomy of patients with depression who respond to placebo to those who recover spontaneously: Is there a biological basis for the placebo effect in depression?

Aaron K. Vallanc

Journal of Affective Disorders. Volume 98, Issues 1-2, February 2007, Pages 177-185

 

Allosteric Modulation of G Protein–Coupled Receptors

Lauren T. May, ­Katie Leach, ­Patrick M. Sexton, and ­Arthur Christopoulos­

Annual Review of Pharmacology and Toxicology. Vol. 47: 1-51

 

Mitochondrial Oxidative Stress: Implications for Cell Death

Sten Orrenius, ­Vladimir Gogvadze, and ­Boris Zhivotovsky­

Annual Review of Pharmacology and Toxicology. Vol. 47: 143-183

 

Antidepressant-Like Effects of Ceftriaxone in Male C57BL/6J Mice

Yann S. Mineur, Marina R. Picciotto and Gerard Sanacora

Biological Psychiatry. Volume 61, Issue 2, 15 January 2007, Pages 250-252

 

Chronic Treatment with Mood Stabilizers Increases Membrane GRK3 in Rat Frontal Cortex

Renee N. Ertley, Richard P. Bazinet, Ho-Joo Lee, Stanley I. Rapoport and Jagadeesh S. Rao

Biological Psychiatry. Volume 61, Issue 2, 15 January 2007, Pages 246-249

 

Effect of Chronic Administration of Duloxetine on Serotonin and Norepinephrine Transporter Binding Sites in Rat Brain

Georgianna G. Gould, Martin A. Javors and Alan Frazer

Biological Psychiatry. Volume 61, Issue 2, 15 January 2007, Pages 210-215

 

Decreased Plasma Brain Derived Neurotrophic Factor Levels in Unmedicated Bipolar Patients During Manic Episode

Rodrigo Machado-Vieira, Marcelo O. Dietrich, Renata Leke, Vitor H. Cereser, Vanessa Zanatto, Flavio Kapczinski, Diogo O. Souza, Luis V. Portela and Valentim Gentil

Biological Psychiatry. Volume 61, Issue 2, 15 January 2007, Pages 142-144

 

Abnormal glucose metabolism in the anterior cingulate cortex in patients with schizophrenia

Toshiro Fujimoto, Kouzou Takeuch, Tetsuro Matsumoto, Kiyohisa Kamimura, Ryuichiro Hamada, Katsumi Nakamura and Nobumasa Kato

Psychiatry Research: Neuroimaging. Volume 154, Issue 1, 15 January 2007, Pages 49-58

 

Displacement of Serotonin and Dopamine Transporters by Venlafaxine Extended Release Capsule at Steady State: A [123I]2[beta]-Carbomethoxy-3[beta]-(4-Iodophenyl)-Tropane Single Photon Emission Computed Tomography Imaging Study

Shang, Yili; Gibbs, Megan A; Marek, Gerard J; Stiger, Thomas; Burstein, Aaron H; Marek, Kenneth; Seibyl, John P; Rogers, Janyce F

Journal of Clinical Psychopharmacology. 27(1):71-75, February 2007

Development of functionally selective agonists as novel therapeutic agents

Kelly A. Berg and William P. Clarke

Drug Discovery Today: Therapeutic Strategies. Volume 3, Issue 4, Winter 2006, Pages 421-428

 

Partial agonism of dopamine, serotonin and opiate receptors for psychiatry

Frank Yocca and C. Anthony Altar

Drug Discovery Today: Therapeutic Strategies. Volume 3, Issue 4, Winter 2006, Pages 429-435

 

Heterodimers of G protein-coupled receptors as novel and distinct drug targets

Raphael Rozenfeld, Fabien M. Décaillot, Adriaan P. IJzerman and Lakshmi A. Devi

Drug Discovery Today: Therapeutic Strategies. Volume 3, Issue 4, Winter 2006, Pages 437-443

 

In-Target versus Off-Target allosteric modulators of GPCRs

Juan Ballesteros and John Ransom

Drug Discovery Today: Therapeutic Strategies. Volume 3, Issue 4, Winter 2006, Pages 445-450

 

RNA interference as a therapeutic strategy for treating CNS disorders

Daniel Hoyer and Kumlesh K. Dev

Drug Discovery Today: Therapeutic Strategies. Volume 3, Issue 4, Winter 2006, Pages 451-456

 

GABAA receptor modulators as anxioselective anxiolytics

Anthony S. Basile, Arnold S. Lippa and Phil Skolnick

Drug Discovery Today: Therapeutic Strategies. Volume 3, Issue 4, Winter 2006, Pages 475-481

 

Neurogenesis: What is its role in the cause and cure of depression?

Fritz A. Henn and Barbara Vollmayr

Drug Discovery Today: Therapeutic Strategies. Volume 3, Issue 4, Winter 2006, Pages 503-506

 

Metabotropic glutamate receptor targets for neuropsychiatric disorders

Anni-Maija Linden and Darryle D. Schoepp

Drug Discovery Today: Therapeutic Strategies. Volume 3, Issue 4, Winter 2006, Pages 507-517

 

Enhancing AMPA to NMDA throughput as a convergent mechanism for antidepressant action

Jing Du, Rodrigo Machado-Vieira, Sungho Maeng, Keri Martinowich, Husseini K. Manji and Carlos A. Zarate, Jr

Drug Discovery Today: Therapeutic Strategies. Volume 3, Issue 4, Winter 2006, Pages 519-526

 

Glutamate transport inhibitors as targets for treating psychosis

John Dunlop and Karen Marquis

Drug Discovery Today: Therapeutic Strategies. Volume 3, Issue 4, Winter 2006, Pages 533-537

 

Glycine transporter inhibitors as novel antipsychotics

Christian Thomsen

Drug Discovery Today: Therapeutic Strategies. Volume 3, Issue 4, Winter 2006, Pages 539-545

 

NK3 receptor antagonists for the treatment of schizophrenia

Herbert Meltzer and Adam Prus

Drug Discovery Today: Therapeutic Strategies. Volume 3, Issue 4, Winter 2006, Pages 555-560

 

Endocannabinoids and their receptors as targets for treating metabolic and psychiatric disorders

Christian C. Felder

Drug Discovery Today: Therapeutic Strategies. Volume 3, Issue 4, Winter 2006, Pages 561-567

 

Targeting glycogen synthase kinase-3 in Alzheimer's disease

Hui-Chuan Huang, W. Timothy O’Brien and Peter S. Klein

Drug Discovery Today: Therapeutic Strategies. Volume 3, Issue 4, Winter 2006, Pages 613-619

 

NMDA Receptors in Glia

Alexei Verkhratsky, Frank Kirchhoff

The Neuroscientist, Vol. 13, No. 1, 28-37 (2007)

Wandering Minds: The Default Network and Stimulus-Independent Thought

Malia F. Mason, Michael I. Norton, John D. Van Horn, Daniel M. Wegner, Scott T. Grafton, C. Neil Macrae

Science 19 January 2007: Vol. 315. no. 5810, pp. 393 - 395

Subcortical visual dysfunction in schizophrenia drives secondary cortical impairments

Pamela D. Butler, Antigona Martinez, John J. Foxe, Dongsoo Kim, Vance Zemon, Gail Silipo, Jeannette Mahoney, Marina Shpaner, Maria Jalbrzikowski and Daniel C. Javitt

Brain 2007 130(2):417-430

 

The role of phospholipase A2 in neuronal homeostasis and memory formation: implications for the pathogenesis of Alzheimer’s disease

Review

The role of phospholipase A2 in neuronal homeostasis and memory formation: implications for the pathogenesis of Alzheimer’s disease

O. V. Forlenza, E. L. Schaeffer and W. F. Gattaz

Journal of Neural Transmission. Volume 114, Number 2 / February, 2007: 231-238

 

Changes in region- and cell type-specific expression patterns of neutral amino acid transporter 1 (ASCT-1) in the anterior cingulate cortex and hippocampus in schizophrenia, bipolar disorder and major depression

Changes in region- and cell type-specific expression patterns of neutral amino acid transporter 1 (ASCT-1) in the anterior cingulate cortex and hippocampus in schizophrenia, bipolar disorder and major depression

S. Weis, I. C. Llenos, J. R. Dulay, N. Verma, S. Sabunciyan and R. H. Yolken

Journal of Neural Transmission. Volume 114, Number 2 / February, 2007: 261-271

 

Time Course of the Antipsychotic Effect and the Underlying Behavioral Mechanisms

Ming Li, Paul J Fletcher and Shitij Kapur

Neuropsychopharmacology (2007) 32, 263–272

 

Olanzapine-Induced Weight Gain and Increased Visceral Adiposity is Blocked by Melatonin Replacement Therapy in Rats

MurrayRaskind, Brianna L Burke, Norman J Crites, Andre M Tapp and Dennis D Rasmussen

Neuropsychopharmacology (2007) 32, 284–288

 

Acute Effects of Atypical Antipsychotics on Whole-Body Insulin Resistance in Rats: Implications for Adverse Metabolic Effects

Karen L Houseknecht, Alan S Robertson, William Zavadoski, E Michael Gibbs, David E Johnson and Hans Rollema

Neuropsychopharmacology (2007) 32, 289–297


The brain's master circadian clock: Implications and opportunities for therapy of sleep disorders

Phyllis C. Zee and Prasanth Manthena

Sleep Medicine Reviews. Volume 11, Issue 1, February 2007, Pages 59-70

 

Evidence for Reduced Cerebellar Volumes in Trichotillomania

Nancy J. Keuthen, Nikos Makris, John E. Schlerf, Brian Martis, Cary R. Savage, Katherine McMullin, Larry J. Seidman, Jeremy D. Schmahmann, David N. Kennedy, Steven M. Hodge and Scott L. Rauch

Biological Psychiatry. Volume 61, Issue 3, 1 February 2007, Pages 374-381


Effects of amphetamine isomers, methylphenidate and atomoxetine on synaptosomal and synaptic vesicle accumulation and release of dopamine and noradrenaline in vitro in the rat brain

Neil Easton, Carolyn Steward, Fiona Marshall, Kevin Fone and Charles Marsden

Neuropharmacology. Volume 52, Issue 2, February 2007, Pages 405-414

 

Influence of clozapine on platelet serotonin, monoamine oxidase and plasma serotonin levels

Aygun Ertugrul, Gulberk Ucar, Koray Basar, Basaran Demir, Samiye Yabanoglu and Berna Ulug

Psychiatry Research. Volume 149, Issues 1-3, 15 January 2007, Pages 49-57

 

Region-specific transcriptional changes following the three antidepressant treatments electro convulsive therapy, sleep deprivation and fluoxetine

B Conti, R Maier, A M Barr, M C Morale, X Lu, P P Sanna, G Bilbe, D Hoyer and T Bartfai

Molecular Psychiatry (2007) 12, 167–189

.

Regresar a RESÚMENES ENERO 2007